Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypofractionated Intensity-modulated Radiation Therapy With Concurrent Chemotherapy in Musc Le-invasive Bladder Cancer:

NCT05453682 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT05453682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05453682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypofractionated Intensity-modulated Radiation Therapy With Concurrent Chemotherapy in Musc Le-invasive Bladder Cancer:
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
May 14, 2021
Completion date
December 31, 2029
Enrollment
53 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer